INVO Fertility, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $44.80 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-02.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-06-02
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.62, a 83.60% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $3.78, a 62.23% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-03-31 was $2.33, a 959.09% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2020-03-31 was $0.22.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $44.80.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $7.74, a 115.60% increase from fiscal 2022.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $3.59, a 14.33% increase from fiscal 2021.
- INVO Fertility, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $3.14, a 51.01% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $44.80 10-K · filed 2026-06-02 | |||||
| 2025-09-30 | $1.12 10-Q · filed 2025-11-17 | |||||
| 2023-12-31 | $7.74 10-K/A · filed 2024-11-19 | |||||
| 2023-09-30 | $7.74 10-Q · filed 2023-11-13 | |||||
| 2023-06-30 | $7.74 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | $0.62 10-Q · filed 2023-05-15 | |||||
| 2022-12-31 | $3.59 10-K · filed 2023-04-17 | |||||
| 2022-09-30 | $3.70 10-Q · filed 2022-11-14 | |||||
| 2022-06-30 | $3.65 10-Q · filed 2022-08-15 | |||||
| 2022-03-31 | $3.78 10-Q · filed 2022-05-16 | |||||
| 2021-12-31 | $3.14 10-K · filed 2022-03-31 | |||||
| 2021-09-30 | $3.14 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | $3.14 10-Q · filed 2021-08-16 | |||||
| 2021-03-31 | $2.33 10-Q · filed 2021-05-17 | |||||
| 2020-12-31 | $6.41 10-K · filed 2021-03-30 | |||||
| 2020-11-27 | $3.16 10-K · filed 2021-03-30 | |||||
| 2020-10-16 | $8.16 10-K · filed 2021-03-30 | |||||
| 2020-09-30 | $6.47 10-Q · filed 2020-11-16 | |||||
| 2020-08-11 | $5.76 10-K · filed 2021-03-30 | |||||
| 2020-06-30 | $4.44 10-Q · filed 2020-08-13 | |||||
| 2020-04-06 | $8.32 10-K · filed 2021-03-30 | |||||
| 2020-03-31 | $0.22 10-Q · filed 2020-05-15 | |||||
| 2020-03-23 | $8.32 10-K · filed 2021-03-30 | |||||
| 2020-02-05 | $8.07 10-K · filed 2021-03-30 | |||||
| 2020-02-01 | $8.32 10-K · filed 2021-03-30 | |||||
| 2020-01-17 | $6.84 10-K · filed 2021-03-30 | |||||
| 2020-01-06 | $7.04 10-K · filed 2021-03-30 | |||||
| 2019-12-31 | $8.41 10-K · filed 2021-03-30 | $0.26 10-K · filed 2020-03-30 | ||||
| 2019-10-29 | $9.25 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |